Synergistic action of first-in-class anti-tropomyosin compound, ATM-3507 (Anisina) and microtubule targeting inhibitors in pre-clinical models of non-small cell lung cancer (NSCLC). (December 2016) - Stehn, J.; Mariana, A.; Failes, T.; Ashokakumar, V.; Eiffe, E.; Heaton, A.; Hook, J.; Sivanandhan, D.; Arndt, G.; Gunning, P.; Brown, D.